Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $68,685 - $73,918
-445 Reduced 3.2%
13,462 $2.23 Million
Q1 2023

May 12, 2023

SELL
$151.05 - $180.26 $1.19 Million - $1.42 Million
-7,883 Reduced 36.18%
13,907 $2.16 Million
Q4 2022

Feb 13, 2023

BUY
$160.2 - $179.79 $121,271 - $136,101
757 Added 3.6%
21,790 $3.85 Million
Q3 2022

Nov 14, 2022

BUY
$161.33 - $179.52 $296,847 - $330,316
1,840 Added 9.59%
21,033 $3.44 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $160,453 - $177,453
-954 Reduced 4.74%
19,193 $3.41 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $180,754 - $205,271
1,143 Added 6.01%
20,147 $3.57 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $459,057 - $509,341
2,944 Added 18.33%
19,004 $3.25 Million
Q3 2021

Nov 15, 2021

BUY
$161.5 - $179.47 $2.59 Million - $2.88 Million
16,060 New
16,060 $2.59 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Stansberry Asset Management, LLC Portfolio

Follow Stansberry Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stansberry Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stansberry Asset Management, LLC with notifications on news.